NORM-HF Pivotal Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.
Also called NCT07574593
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 800 participants
- Registry
-
NCT07574593
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07574593. Randomized; no masking; primary purpose prevention. Start 2026-05-29 (actual); primary completion 2029-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NORM-HF Pivotal Study
- Acronym
- NORM-HF
- Condition
- Heart Failure
- Condition
- NYHA Class III Heart Failure
- Condition
- NYHA Class II Heart Failure
- Intervention (Device)
- IVC Sensor
- Lead sponsor
- Foundry Innovation & Research 1, Limited (FIRE1)
- Collaborator
- NAMSA
- Collaborator
- Baim Institute for Clinical Research
Record details
- Record id
cardio:ct-nct07574593- Content hash
3d964eac6a714e38dbcc00f65d9ecb7db164075a8213deccf8c0987c00425554